Mortality and Lung Function Decline of Idiopathic Pulmonary Fibrosis Patient with Ezetimibe and Pirfenidone

被引：0
|
作者：
Cho, Jinhyung [1 ]
Lee, Chanho [1 ]
Kwak, Se Hyun [1 ]
Kim, Young Sam [1 ]
机构：
[1] Yonsei Univ, Med Coll, Seoul, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1720
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pirfenidone and mortality in idiopathic pulmonary fibrosis
    Spagnolo, Paolo
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 3 - 5
  • [2] Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone
    Majek, Ondrej
    Gregor, Jakub
    Mogulkoc, Nesrin
    Lewandowska, Katarzyna
    Sterclova, Martina
    Muller, Veronika
    Hajkova, Marta
    Kramer, Mordechai R.
    Tekavec-Trkanjec, Jasna
    Jovanovic, Dragana
    Studnicka, Michael
    Stoeva, Natalia
    Kirchgassler, Klaus-Uwe
    Littnerova, Simona
    Dusek, Ladislav
    Vasakova, Martina Koziar
    PLOS ONE, 2022, 17 (09):
  • [3] DOES RATE OF DECLINE IN LUNG FUNCTION PREDICT RESPONSE TO PIRFENIDONE THERAPY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS?
    Eaden, J. A.
    Barber, C.
    Bianchi, S. M.
    THORAX, 2015, 70 : A64 - A64
  • [4] Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
    Albera, Carlo
    Costabel, Ulrich
    Fagan, Elizabeth A.
    Glassberg, Marilyn K.
    Gorina, Eduard
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Spirig, Dominique
    Swigris, Jeff J.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 843 - 851
  • [5] Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
    Nathan, Steven D.
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim A.
    Kirchgaessler, Klaus-Uwe
    Stauffer, John L.
    Morgenthien, Elizabeth
    Chou, Willis
    Limb, Susan L.
    Noble, Paul W.
    RESPIRATORY MEDICINE, 2019, 153 : 44 - 51
  • [6] Marked Improvement with Pirfenidone in a Patient with Idiopathic Pulmonary Fibrosis
    Miyamoto, Atsushi
    Morokawa, Nasa
    Takahashi, Yui
    Ogawa, Kazumasa
    Takeyasu, Makiko
    Murase, Kyoko
    Hanada, Shigeo
    Uruga, Hironori
    Mochizuki, Sayaka
    Takaya, Hisashi
    Kurosaki, Atsuko
    Kishi, Kazuma
    INTERNAL MEDICINE, 2016, 55 (06) : 657 - 661
  • [7] Pirfenidone photosensitivity rash in a patient with idiopathic pulmonary fibrosis
    Koulelidis, Andreas
    Zacharis, Georgios
    Dolios, Paschalis
    Tzouvelekis, Argyris
    Bouros, Demosthenes
    PNEUMON, 2013, 26 (01) : 96 - 96
  • [8] Pneumocystis Pneumonia In A Patient With Idiopathic Pulmonary Fibrosis On Pirfenidone
    Nasiri, H.
    Oldham, J.
    Louie, S.
    Chan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [9] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
  • [10] PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Maher, T. M.
    DRUGS OF TODAY, 2010, 46 (07) : 473 - 482
12345